← Back to dossier
Patient handout

Aortic dissection in hypertensive crisis (HR + dP/dt FIRST, then SBP)

PRODUCTION

1. Your condition

This handout is for aortic dissection in hypertensive crisis (hr + dp/dt first, then sbp). Your care team identified this based on: sudden tearing chest/back pain ± migrating pain (klompas rce jama 2002 lr+ 10.8 pmid 11990624).

Other reasons your team may use this plan: inter-arm sbp gradient >20 mmhg (acc/aha 2022 aortic pmid 36066317); mediastinal widening on cxr (lr+ for dissection ~3) — triggers cta; cta chest/abdomen/pelvis showing intimal flap → confirms diagnosis (acc/aha 2022 class i).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
esmolol500 µg/kg IV bolus then 50 µg/kg/min infusion, titrate by 25 µg/kg/min q5 min to HR <60 (max 300 µg/kg/min)IVcontinuousACC/AHA 2022 Class I — anti-impulse FIRST; ultra-short half-life allows fine titration; HR <60 within 5-10 min target
labetalol20 mg IV q10 min (max 300 mg cumulative) OR 0.5-2 mg/min infusionIVbolus or infusionACC/AHA 2022 Class I alternative — mixed α/β provides combined HR + SBP control; useful when esmolol not on hand
nicardipine5 mg/h IV (ONLY after HR <60), titrate by 2.5 mg/h q5 min to SBP <120 within 20-30 minIVcontinuousACC/AHA 2022 Class I — add ONLY after esmolol/labetalol established HR <60; SBP target 100-120 with HR <60 within 20-30 min
nitroprusside0.25-10 µg/kg/min IV (ONLY after HR <60 with BB)IVcontinuousAlternative vasodilator after BB; AVOID if eGFR <30 (cyanide); ACC/AHA 2022 acceptable adjunct
AVOID isolated vasodilator without BBAVOIDN/AN/AIsolated vasodilator (nitroprusside, hydralazine, nicardipine without BB) increases dP/dt via reflex tachycardia → propagates dissection (ACC/AHA 2022 Class III)
AVOID hydralazineAVOIDN/AN/AHydralazine causes reflex tachycardia → increases dP/dt → propagation; not recommended in dissection
fentanyl25-100 µg IV q5-10 min titrateIVPRNPain control reduces sympathetic drive (HR + dP/dt); IV opioid preferred for rapid titration

Plan: Aortic dissection — anti-impulse paradigm: HR <60 FIRST (BB), THEN SBP <120 (vasodilator). Goal achieved within 20-30 min.

3. When to call your provider

Contact your care team if any of the following happen:

  • Recurrent pain → STAT CTA + ED
  • New aneurysm on CTA → vascular intervention

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • New / extended dissection flap on serial CTA OR new branch malperfusion on imaging or exam(life-threatening)
  • Type A (ascending) dissection + pericardial effusion + hemodynamic compromise (Beck triad)(life-threatening)
  • Stanford B dissection + branch malperfusion (limb ischemia, mesenteric ischemia, AKI, paraplegia, stroke) OR refractory pain OR rapid aneurysm expansion(life-threatening)
  • Refractory HR >60 or SBP >120 despite maximum esmolol/labetalol + nicardipine — propagation risk(life-threatening)
  • Free flap on CTA, hemothorax, hemoperitoneum, hemodynamic collapse with HTN history(life-threatening)

5. Follow-up

Lifetime aortic surveillance (CTA at 1, 3, 6, 12 mo then yearly); strict BP control to <120/80 outpatient (per ACC/AHA 2022); BB lifelong; genetic testing if Marfan/Loeys-Dietz/EDS suspected; cardiac surgery follow-up if Type A repair

6. Sources

Guideline: 2022 ACC/AHA Aortic Disease Guideline (Isselbacher PMID 36066317) + 2025 ACC/AHA HTN Guideline (Whelton) + ESC/ESH 2024 HTN (Mancia PMID 38613493)

  1. pubmed.ncbi.nlm.nih.gov/36066317
  2. pubmed.ncbi.nlm.nih.gov/17307915
  3. pubmed.ncbi.nlm.nih.gov/25840177